BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
Provided By PR Newswire
Last update: Aug 24, 2024
NEW YORK, Aug. 23, 2024 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both dates inclusive (the "Class Period"), of the important September 3, 2024 lead plaintiff deadline.
Read more at prnewswire.com0.298
-0.03 (-7.97%)
Find more stocks in the Stock Screener
BOLT Latest News and Analysis
a day ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
